Want to join the conversation?
$MDT is seeing strong acceptance for its new therapies across all groups. Including the benefit of extra week, emerging markets growth vector contributed approx. 190BP to 1Q16 total growth. Regionally, Middle East and Africa was weaker, but $MDT reported notable improvements China (low double digits), India (mid teens), and Russia (upper teens).
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?